Search results
Why Novavax Stock More Than Doubled Today
Motley Fool via Yahoo Finance· 3 weeks agoShares of Novavax (NASDAQ: NVAX) are up 12% as of midday Friday following the release of the drugmaker's first-quarter results. It's not the report,...
Novavax Stock May Soar 379%, According to Wall Street. Is the Stock a Buy Right Now?
Motley Fool via Yahoo Finance· 4 months agoNovavax (NASDAQ: NVAX) soared more than 2,700% early in the pandemic as investors bet on its ability...
3 Things You Need to Know If You Buy Novavax Today
The Motley Fool via AOL· 2 weeks agoNovavax (NASDAQ: NVAX) stock has both soared and plummeted at times in recent years. Investors initially bet on the biotech company to be a winner in the...
Novavax (NVAX) Q4 Earnings & Revenues Miss Estimates, Stock Down
Zacks via Yahoo Finance· 1 year agoNovavax (NVAX) reports worse-than-expected financial performance in the fourth quarter of 2022, with...
Novavax Dives As Pfizer, Moderna Snag First Nods For Covid Boosters
Investor's Business Daily· 9 months agoNovavax stock crumbled Monday after the Food and Drug Administration signed off on updated Covid...
Novavax's (NVAX) Updated COVID Jab Gets WHO Nod for Emergency Use
Zacks via Yahoo Finance· 6 months agoNovavax NVAX announced that the World Health Organization (“WHO”) has granted emergency use listing...
Has Novavax Just Solved Its Biggest Problem?
Motley Fool via Yahoo Finance· 3 months agoMany investors have seen Novavax (NASDAQ: NVAX) as a promising recovery story ever since the biotech launched a plan to cut costs to better match the...
FDA authorizes Novavax as new alternative to mRNA COVID-19 vaccines
CBS News via Yahoo News· 2 years agoThe Food and Drug Administration has granted Novavax's COVID-19 vaccine emergency use authorization,...
Will Novavax's Covid Booster Thesis Play Out? What The Survey Says
Investor's Business Daily· 2 years agoNovavax's Covid booster is preemptively gaining steam, according to the July IBD/TIPP Poll. The...
IBD/TIPP Poll: There's Bad News For Novavax's Covid Vaccine
Investor's Business Daily· 2 years agoNovavax could struggle to find a U.S. market for its Covid vaccine, according to the latest IBD/TIPP...